Related Experiment Video
Updated: Aug 27, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
[Extracorporeal Ventricular Assist Device for Acute Cardiogenic Shock]
Hiromichi Sonoda1, Akira Shiose
1Department of Cardiovascular Surgery, Kyushu University, Fukuoka, Japan.
Abstract:
Various diseases cause acute cardiogenic shocks, such as fulminant myocarditis and acute myocardial infarction, but if medical treatment as an induction therapy is not effective, mechanical circulatory support (MCS) should be promptly converted. Intraaortic balloon pumping (IABP) and peripheral veno-arterial extracorporeal membrance oxygenation( V-A ECMO)[percutaneous cardiopulmonary support (PCPS)] are generally used as MCS that can be easily introduced via the groin. Still, there are some cases in which recovery of cardiac function cannot be achieved even after the acute phase therapies. This article will explain the extracorporeal ventricular assist device as a more powerful MCS after IABP or V-A ECMO as induction therapy.
More Related Videos
Related Concept Videos
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy II: Dilated Cardiomyopathy
Acute Respiratory Failure-IV
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies

